Literature DB >> 10465784

ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.

E Kopp1, R Medzhitov, J Carothers, C Xiao, I Douglas, C A Janeway, S Ghosh.   

Abstract

Activation of NF-kappaB as a consequence of signaling through the Toll and IL-1 receptors is a major element of innate immune responses. We report the identification and characterization of a novel intermediate in these signaling pathways that bridges TRAF6 to MEKK-1. This adapter protein, which we have named ECSIT (evolutionarily conserved signaling intermediate in Toll pathways), is specific for the Toll/IL-1 pathways and is a regulator of MEKK-1 processing. Expression of wild-type ECSIT accelerates processing of MEKK-1, whereas a dominant-negative fragment of ECSIT blocks MEKK-1 processing and activation of NF-kappaB. These results indicate an important role for ECSIT in signaling to NF-kappaB and suggest that processing of MEKK-1 is required for its function in the Toll/IL-1 pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465784      PMCID: PMC316957          DOI: 10.1101/gad.13.16.2059

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  52 in total

Review 1.  The Toll-receptor family and control of innate immunity.

Authors:  E B Kopp; R Medzhitov
Journal:  Curr Opin Immunol       Date:  1999-02       Impact factor: 7.486

2.  The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.

Authors:  J Ninomiya-Tsuji; K Kishimoto; A Hiyama; J Inoue; Z Cao; K Matsumoto
Journal:  Nature       Date:  1999-03-18       Impact factor: 49.962

3.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

4.  Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region.

Authors:  A Poltorak; I Smirnova; X He; M Y Liu; C Van Huffel; O McNally; D Birdwell; E Alejos; M Silva; X Du; P Thompson; E K Chan; J Ledesma; B Roe; S Clifton; S N Vogel; B Beutler
Journal:  Blood Cells Mol Dis       Date:  1998-09       Impact factor: 3.039

5.  A Drosophila TNF-receptor-associated factor (TRAF) binds the ste20 kinase Misshapen and activates Jun kinase.

Authors:  H Liu; Y C Su; E Becker; J Treisman; E Y Skolnik
Journal:  Curr Biol       Date:  1999-01-28       Impact factor: 10.834

6.  Inhibition of NF-kappa B by sodium salicylate and aspirin.

Authors:  E Kopp; S Ghosh
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

7.  ASK1 is essential for JNK/SAPK activation by TRAF2.

Authors:  H Nishitoh; M Saitoh; Y Mochida; K Takeda; H Nakano; M Rothe; K Miyazono; H Ichijo
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

8.  Insect immunity: developmental and inducible activity of the Drosophila diptericin promoter.

Authors:  J M Reichhart; M Meister; J L Dimarcq; D Zachary; D Hoffmann; C Ruiz; G Richards; J A Hoffmann
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

9.  Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

Authors:  S T Qureshi; L Larivière; G Leveque; S Clermont; K J Moore; P Gros; D Malo
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

10.  Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.

Authors:  C J Kirschning; H Wesche; T Merrill Ayres; M Rothe
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  71 in total

Review 1.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors:  G Zhang; S Ghosh
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling.

Authors:  A Bowie; E Kiss-Toth; J A Symons; G L Smith; S K Dower; L A O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 3.  Toll receptors: a central element in innate immune responses.

Authors:  Thierry Vasselon; Patricia A Detmers
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

5.  Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis.

Authors:  Changchun Xiao; Jae-hyuck Shim; Michael Klüppel; Samuel Shao-Min Zhang; Chen Dong; Richard A Flavell; Xin-Yuan Fu; Jeffrey L Wrana; Brigid L M Hogan; Sankar Ghosh
Journal:  Genes Dev       Date:  2003-11-21       Impact factor: 11.361

6.  A heterotrimeric death domain complex in Toll signaling.

Authors:  Huaiyu Sun; Benjamin N Bristow; Guowei Qu; Steven A Wasserman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-26       Impact factor: 11.205

7.  An ECSIT-centric view of Alzheimer's disease.

Authors:  Mark P Mattson
Journal:  Bioessays       Date:  2012-05-29       Impact factor: 4.345

8.  Physical and functional interactions between Drosophila TRAF2 and Pelle kinase contribute to Dorsal activation.

Authors:  B Shen; H Liu; E Y Skolnik; J L Manley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

9.  MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colony-stimulating factor production in macrophages.

Authors:  Kihwan Kim; Omar Duramad; Xiao-Feng Qin; Bing Su
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

10.  Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways.

Authors:  Dongyu Zhang; Valeria Facchinetti; Xiaofang Wang; Qiaojia Huang; Jun Qin; Bing Su
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.